Stock Research: Chong Kun Dang

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Chong Kun Dang

KOSE:A185750 KR7185750007
42
  • Value
    61
  • Growth
    4
  • Safety
    Safety
    46
  • Combined
    14
  • Sentiment
    84
  • 360° View
    360° View
    42
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Chong Kun Dang Pharmaceutical Corp manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs, quasi-drugs, and health functional foods. The company operates in the pharmaceutical and healthcare industries, with products including antidiabetic treatments, cerebrovascular disease treatments, and OTC drugs like penzal. It sells products domestically and internationally. In the last fiscal year, the company had a market cap of $821 million, profits of $361 million, and revenue of $1074 million. The number of employees is not available.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 42 (better than 42% compared with alternatives), overall professional sentiment and financial characteristics for the stock Chong Kun Dang are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Chong Kun Dang. The consolidated Sentiment Rank has a good rank of 84, which means that professional investors are more optimistic about the stock than for 84% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 61 or better than 61% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 46, meaning that the share price of Chong Kun Dang is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 4. ...read more

more
Index
KOSPI
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
46 46 34 51
Growth
4 6 93 15
Safety
Safety
61 65 34 55
Sentiment
84 76 98 73
360° View
360° View
42 46 85 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
82 88 69 82
Opinions Change
50 26 64 50
Pro Holdings
n/a 64 80 10
Market Pulse
95 76 89 93
Sentiment
84 76 98 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
46 46 34 51
Growth
4 6 93 15
Safety Safety
61 65 34 55
Combined
14 49 50 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
42 51 40 51
Price vs. Earnings (P/E)
88 84 70 87
Price vs. Book (P/B)
44 43 29 39
Dividend Yield
39 34 31 32
Value
46 46 34 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
47 27 21 40
Profit Growth
12 11 89 16
Capital Growth
5 31 84 85
Stock Returns
40 26 93 5
Growth
4 6 93 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
45 43 31 40
Refinancing
84 80 53 71
Liquidity
41 57 45 47
Safety Safety
61 65 34 55

Similar Stocks

Discover high‑ranked alternatives to Chong Kun Dang and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

AMOREPACIFIC

KOSE:A002790
Country: South Korea
Industry: Personal Products
Size: Medium
Full Stock Analysis

Samsung Engineering

KOSE:A028050
Country: South Korea
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

NH Investment & Securities

KOSE:A005940
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.